BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33832504)

  • 21. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
    Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
    Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of temperature treatment before cryopreservation on the viability and potency of cryopreserved and thawed CD34
    Schwandt S; Liedtke S; Kogler G
    Cytotherapy; 2017 Aug; 19(8):962-977. PubMed ID: 28645734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.
    Hussein E; DeFor T; Wagner JE; Sumstad D; Brunstein CG; McKenna DH
    Transfusion; 2020 Jan; 60(1):144-154. PubMed ID: 31756003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometry quantification of CD34+ cells and other leukocyte subpopulations in frozen-thawed blood cell suspensions: investigation of a new teflon container for cryopreservation of hematopoietic progenitor cells.
    Arseniev L; Goudeva L; Kadar JG; Südmeier I; Battmer K; Matheja S; Mitschulat H; Stangel W; Link H
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):152-8. PubMed ID: 7543782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
    Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.
    Stylianou J; Vowels M; Hadfield K
    Cytotherapy; 2006; 8(1):57-61. PubMed ID: 16627345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.
    Sartor M; Antonenas V; Garvin F; Webb M; Bradstock KF
    Bone Marrow Transplant; 2005 Aug; 36(3):199-204. PubMed ID: 15937512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation.
    Abbruzzese L; Agostini F; Durante C; Toffola RT; Rupolo M; Rossi FM; Lleshi A; Zanolin S; Michieli M; Mazzucato M
    Vox Sang; 2013 Jul; 105(1):77-80. PubMed ID: 23384290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw.
    Castelhano MV; Reis-Alves SC; Vigorito AC; Rocha FF; Pereira-Cunha FG; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2013 Apr; 48(2):241-6. PubMed ID: 23394728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts.
    Lanza F; Moretti S; Castagnari B; Montanelli F; Latorraca A; Ferrari L; Bardi A; Dominici M; Campioni D; Dabusti M; Piva N; Lodi G; Reverberi R; Castoldi G
    Haematologica; 1999 Nov; 84(11):969-77. PubMed ID: 10553156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: effect of the CD34+ cell dose.
    Diaz MA; Vicent MG; Garcia-Sanchez F; Vicario JL; Madero L
    Vox Sang; 2000; 79(3):145-50. PubMed ID: 11111232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fresh or Cryopreserved CD34
    Ghobadi A; Fiala MA; Ramsingh G; Gao F; Abboud CN; Stockerl-Goldstein K; Uy GL; Grossman BJ; Westervelt P; DiPersio JF
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1072-1077. PubMed ID: 28323004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor.
    Kawano Y; Takaue Y; Watanabe A; Takeda O; Arai K; Itoh E; Ohno Y; Teshima T; Harada M; Watanabe T; Okamoto Y; Abe T; Kajiume T; Matsushita T; Ikeda K; Endo M; Kuroda Y; Asano S; Tanosaki R; Yamaguchi K; Law P; McMannis JD
    Blood; 1998 Nov; 92(9):3123-30. PubMed ID: 9787147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
    Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
    Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.